Table 1.
Clinical characteristics of the study population.
| Sex, female | 17 (18) |
| Hypertension | 54 (57) |
| Ischemic aetiology | 46 (48) |
| Impaired glucose tolerance | 13 (14) |
| Diabetes | 19 (20) |
| Overweight (BMI ≥ 25 kg/m2) | 40 (43) |
| Stage 1 obesity (BMI 30–34.99 kg/m2) | 15 (16) |
| Stage 2 obesity (BMI 35–40 kg/m2) | 9 (10) |
| Atrial fibrillation | 21 (22) |
| ICD | 45 (47) |
| CRT-D | 11 (12) |
| NYHA class III–IV | 21 (22) |
Data are expressed as n° (frequency percentage). BMI: Body Mass Index, CRT-D: cardiac resynchronisation therapy-defibrillator, and ICD: implantable cardioverter-defibrillator, NYHA: New York Heart Association.